» Articles » PMID: 18595737

Chronic Vagus Nerve Stimulation for Treatment-resistant Depression Decreases Resting Ventromedial Prefrontal Glucose Metabolism

Overview
Journal Neuroimage
Specialty Radiology
Date 2008 Jul 4
PMID 18595737
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Vagus nerve stimulation (VNS) is used as an adjunctive therapy for treatment-resistant depression (TRD). Its mechanism of action is not fully understood. Longitudinal measurement of changes in brain metabolism associated with VNS can provide insights into this new treatment modality. Eight severely depressed outpatients who were highly treatment-resistant underwent electrical stimulation of the left vagus nerve for approximately one year. The main outcome measures were resting regional brain glucose uptake measured with positron emission tomography (PET) and the 24-item Hamilton Depression Scale. The most significant and extensive change over one year of chronic VNS localized to the ventromedial prefrontal cortex extending from the subgenual cingulate to the frontal pole. This region continued to decline in metabolism even toward the end of the study. Clinically, this cohort showed a trend for improvement. No correlations surfaced between change in glucose uptake and depression scores. However, the sample size was small; none remitted; and the range of depression scores was limited. Chronic VNS as adjunctive therapy in patients with severe TRD produces protracted and robust declines in resting brain activity within the ventromedial prefrontal cortex, a network with dense connectivity to the amygdala and structures monitoring the internal milieu.

Citing Articles

Acute vagus nerve stimulation enhances reversal learning in rats.

Altidor L, Bruner M, Deslauriers J, Garman T, Ramirez S, Dirr E Neurobiol Learn Mem. 2021; 184:107498.

PMID: 34332068 PMC: 10288030. DOI: 10.1016/j.nlm.2021.107498.


A Review of Parameter Settings for Invasive and Non-invasive Vagus Nerve Stimulation (VNS) Applied in Neurological and Psychiatric Disorders.

Thompson S, OLeary G, Austelle C, Gruber E, Kahn A, Manett A Front Neurosci. 2021; 15:709436.

PMID: 34326720 PMC: 8313807. DOI: 10.3389/fnins.2021.709436.


Variability of white matter anatomy in the subcallosal cingulate area.

Tsolaki E, Sheth S, Pouratian N Hum Brain Mapp. 2021; 42(7):2005-2017.

PMID: 33484503 PMC: 8046077. DOI: 10.1002/hbm.25341.


Over-activation of primate subgenual cingulate cortex enhances the cardiovascular, behavioral and neural responses to threat.

Alexander L, Wood C, Gaskin P, Sawiak S, Fryer T, Hong Y Nat Commun. 2020; 11(1):5386.

PMID: 33106488 PMC: 7588412. DOI: 10.1038/s41467-020-19167-0.


A preliminary study of resting brain metabolism in treatment-resistant depression before and after treatment with olanzapine-fluoxetine combination.

Pardo J, Sheikh S, Schwindt G, Lee J, Adson D, Rittberg B PLoS One. 2020; 15(1):e0226486.

PMID: 31931515 PMC: 6957341. DOI: 10.1371/journal.pone.0226486.


References
1.
Dunner D, Rush A, Russell J, Burke M, Woodard S, Wingard P . Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression. J Clin Psychiatry. 2006; 67(5):688-95. DOI: 10.4088/jcp.v67n0501. View

2.
Harris G, Wimmer M, Randall-Thompson J, Aston-Jones G . Lateral hypothalamic orexin neurons are critically involved in learning to associate an environment with morphine reward. Behav Brain Res. 2007; 183(1):43-51. PMC: 2030620. DOI: 10.1016/j.bbr.2007.05.025. View

3.
Kilpatrick L, Zald D, Pardo J, Cahill L . Sex-related differences in amygdala functional connectivity during resting conditions. Neuroimage. 2005; 30(2):452-61. DOI: 10.1016/j.neuroimage.2005.09.065. View

4.
Nobler M, Oquendo M, Kegeles L, Malone K, CAMPBELL C, Sackeim H . Decreased regional brain metabolism after ect. Am J Psychiatry. 2001; 158(2):305-8. DOI: 10.1176/appi.ajp.158.2.305. View

5.
Mayberg H, Brannan S, Tekell J, Silva J, Mahurin R, McGinnis S . Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry. 2000; 48(8):830-43. DOI: 10.1016/s0006-3223(00)01036-2. View